Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BIO-acetoxime
Cat. No.:
OB0225LY-0090
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
BIO-acetoxime is a small molecule and can be used as a potent dual GSK3α/β inhibitor.
Synonym:
BIA; GSK-3 Inhibitor X; 667463-85-6; (2Z,3E)-3-(Acetoxyimino)-6'-bromo-[2,3'-biindolinylidene]-2'-one; [(E)-[2-(6-Bromo-2-hydroxy-1H-indol-3-yl)indol-3-ylidene]amino] acetate; 6-Bromoindirubin-3'-acetoxime, BIA; [(E)-[(2Z)-2-(6-Bromo-2-oxo-indolin-3-ylidene)indolin-3-ylidene]amino] acetate; [(3E)-2-[(3Z)-6-Bromo-2-oxo-2,3-dihydro-1H-indol-3-ylidene]-2,3-dihydro-1H-indol-3-ylidene]amino acetate; 3-{3-[(Acetyloxy)imino]-1,3-dihydro-2H-indol-2-ylidene}-6-bromo-1,3-dihydro-2H-indol-2-one
CAS No.:
667463-85-6
Compound CID:
135398521
Formula:
C18H12BrN3O3
Formula Weight:
398.21
Specification
Relative Density:
1.69 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
BIO-acetoxime can be used to inhibit GSK3α/β.
Library Information
Targets:
GSK-3 family
Receptors:
GSK-3α; GSK-3β
Pathways:
PI3K/Akt/mTOR signaling; Microbiology/Virology; Stem cells; Apoptosis
Plate Number:
AOCL-2
Plate Location:
b3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
8 mg/mL; 20 mM
